Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.

Matrix metalloproteinase (MMP) 1 and 3 genes play an important role in initiating tumor growth and promoting cell spread. Since MMP1 and MMP3 transcription levels can be modulated by promoter polymorphism, we investigated the impact of different genotypes on the occurrence of head and neck cancer in a Caucasian case control study. DNA was extracted from 126 male head and neck cancer patients and from 249 male hospitalized-based controls. Genotyping was carried out using PCR multiplex allowing the co-amplification of MMAP1-1607 bp and MMP3-1171 bp polymorphisms. PCR products were separated on a capillary electrophoresis. The MMP1-2G and the MMP3-6A allele frequencies were significantly lower in cases than in controls. In particular homozygous 2G/2G individuals were at lower risk of cancer than the 1G/1G carriers (OR= 0.37 95%CI [0.19-0.71], p=0.003). MMP1 and MMP3 polymorphisms were in moderate linkage disequilibrium in cases and controls (D'=0.41 and D'=0.46). Haplotype frequencies distribution derived from these 2 polymorphisms was significantly different between cases and controls (p=0.01). The haplotype analysis suggested an implication of both MMP1 and MMP3 polymorphisms in the head and neck squamous cell carcinoma susceptibility. Indeed, the presence of the MMP1-2G and MMP3-6A alleles seemed to be associated with decreased risk of head and neck squamous cell carcinoma but mainly when they were carried by the same haplotype. By comparison to the 1G-5A haplotype, the 2G-6A haplotype was associated with a lower risk of head and neck squamous cell carcinoma (OR=0.52 95%CI [0.34-0.80], p=0.003).

[1]  Y. Hinoda,et al.  A single nucleotide polymorphism in the matrix metalloproteinase‐1 promoter is associated with conventional renal cell carcinoma , 2003, International journal of cancer.

[2]  C. Brinckerhoff,et al.  Potential for the 2G single nucleotide polymorphism in the promoter of matrix metalloproteinase to enhance gene expression in normal stromal cells. , 2002, Cancer research.

[3]  H. Izawa,et al.  Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. , 2002, The New England journal of medicine.

[4]  M. Oka,et al.  Association of functional polymorphisms of matrix metalloproteinase (MMP)‐1 and MMP‐3 genes with colorectal cancer , 2002, International journal of cancer.

[5]  M. Biondi,et al.  A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  E. Masini,et al.  Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck , 2002, Cancer.

[7]  Jean-Louis Golmard,et al.  Specific haplotypes of the P-selectin gene are associated with myocardial infarction. , 2002, Human molecular genetics.

[8]  P. Amouyel,et al.  Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. , 2002, Journal of the American College of Cardiology.

[9]  M. Biondi,et al.  Independent risk factor for moderate to severe internal carotid artery stenosis: T786C mutation of the endothelial nitric oxide synthase gene. , 2002, Clinical chemistry.

[10]  Hongbing Shen,et al.  Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  V. Kähäri,et al.  Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets , 2002, International journal of cancer.

[12]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[13]  M. Urbanek,et al.  A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 (MMP-1) Promoter Influences Amnion Cell MMP-1 Expression and Risk for Preterm Premature Rupture of the Fetal Membranes* , 2002, The Journal of Biological Chemistry.

[14]  Tianxia Wu,et al.  Interaction between a single nucleotide polymorphism in the alcohol dehydrogenase 3 gene, alcohol consumption and oral cancer risk , 2002, International journal of cancer.

[15]  C. Balabaud,et al.  Involvement of matrix metalloproteinase type‐3 in hepatocyte growth factor‐induced invasion of human hepatocellular carcinoma cells , 2002, International journal of cancer.

[16]  G. Mills,et al.  A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Lung Cancer Susceptibility , 2001 .

[17]  M. Loriot,et al.  Glutathione‐associated enzymes in head and neck squamous cell carcinoma and response to cisplatin‐based neoadjuvant chemotherapy , 2001, International journal of cancer.

[18]  M. Biondi,et al.  Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  A. Olshan,et al.  GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. , 2001, American journal of epidemiology.

[20]  J. Satsangi,et al.  A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. , 2001, Gastroenterology.

[21]  H. Moon,et al.  Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. , 2001, Cancer research.

[22]  M. Spitz,et al.  XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. , 2000, Carcinogenesis.

[23]  S. Ye.  Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[24]  Yusuke Nakamura,et al.  A Single Nucleotide Polymorphism in the Matrix Metalloproteinase‐1 Promoter in Endometrial Carcinomas , 2000, Japanese journal of cancer research : Gann.

[25]  B. Fingleton,et al.  Matrix metalloproteinases: biologic activity and clinical implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  M. Spitz,et al.  Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. , 1999, Carcinogenesis.

[27]  P. Beaune,et al.  GSTM1, smoking and lung cancer: a case-control study. , 1999, International journal of epidemiology.

[28]  Y. Nakamura,et al.  Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. , 1999, Cancer research.

[29]  D. Pinkel,et al.  The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.

[30]  C. Iwai,et al.  Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. , 1999, Circulation.

[31]  J. Gusella,et al.  A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. , 1998, Cancer research.

[32]  J. Ferlay,et al.  Head and neck cancer: a global perspective on epidemiology and prognosis. , 1998, Anticancer research.

[33]  M. Spitz,et al.  Molecular epidemiology and retinoid chemoprevention of head and neck cancer. , 1997, Journal of the National Cancer Institute.

[34]  A. Henney,et al.  Progression of Coronary Atherosclerosis Is Associated with a Common Genetic Variant of the Human Stromelysin-1 Promoter Which Results in Reduced Gene Expression* , 1996, The Journal of Biological Chemistry.

[35]  L. Tiret,et al.  Testing for association between disease and linked marker loci: a log-linear-model analysis. , 1991, American journal of human genetics.

[36]  M. Spitz,et al.  XPD / ERCC 2 polymorphisms and risk of head and neck cancer : a case-control analysis , 2000 .

[37]  L. Coussens,et al.  Matrix metalloproteinases and the development of cancer. , 1996, Chemistry & biology.